The global HER2 antibody market is projected to grow at a CAGR of 8%-10% during 2020-2025. The growth of HER2 antibody market is driven by increasing prevalence of HER2 positive, rising awareness of personalized medicines, and increasing geriatric population.
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the
most promising, high-growth opportunities for the HER2 antibody market by type
of treatment drugs (trastuzumab, lapatinib, ado-trastuzumab emtansine,
pertuzumab, and everolimus), application (hospitals and medical centers),
distribution channel (hospital pharmacies, retail pharmacies, online
pharmacies, and others) and region (North America, Europe, Asia Pacific, and
Rest of the World)?
Q.2 Which segments will
grow at a faster pace and why?
Q.3 What are the
business risks and threats to the HER2 antibody market?
Q.4 What are some
changing demands of customers in the HER2 antibody market?
Q.5 What are the new
developments in the HER2 antibody market? Which companies are leading these
developments?
Q.6 What strategic
initiatives are being implemented by key players for business growth?
Q.7 What are some of the
competitive products and processes in this HER2 antibody area and how big of a
threat do they pose for loss of market share via product substitution?
Q.8 What M&A
activity has occurred in the last 5 years in this HER2 antibody market?
Download Brochure of this report by clicking on https://www.lucintel.com/her2-antibody-market.aspx
Market Segmentation:
Based on type of
treatment drugs, the HER2 antibody market is segmented into trastuzumab,
lapatinib, ado-trastuzumab emtansine, pertuzumab, and everolimus. The trastuzumab
segment accounted for the largest share of the market in 2020 due to increasing
prevalence of cancer.
North America is
expected to be the highest growth over the forecast period over the forecast
period due to developed healthcare infrastructure and increasing awareness of
population regarding the treatment of HER2 breast cancer in the region.
Key Players in the HER2
antibody market are Roche, Novartis, Abnova, Pfizer, InvivoGen, Biocon,
Bio-Techne, Samsung Bioepis and Celltrion.
Request Sample Pages by clicking on https://www.lucintel.com/her2-antibody-market.aspx
The
report helps stakeholders understand the pulse of the market and provides them
with information on key drivers, restraints, challenges, and opportunities for
market growth. It would also help to understand the competitors better and gain
more insights to improve their position in the business.
To read more about this market please click on
https://www.lucintel.com/her2-antibody-market.aspx
About
Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Brandon
Fitzgerald
Lucintel
Dallas,
Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Minimally
Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx
Endoscopy
Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx
Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx
Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx
Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx
Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx
Tumor
Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx
Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx
Urology
Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx
Gene Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx
No comments:
Post a Comment